Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • The collaborative advantage in therapeutic genome editing
the collaborative advantage cell and gene
Infographic

The collaborative advantage in therapeutic genome editing

Not all collaborations and partnerships are equal. This infographic illustrates how our partnership model for the Pin-point™ base editing platform supports you and your team at every stage of the therapeutic development journey to help accelerate timelines, optimize outcomes, and build lasting capabilities.

Inside this infographic:

  • The difference between collaborative and transactional partnership models
  • How our base editing partnership model differs from a traditional model
  • An example of collaboration in action

Download now to explore how such a partnership model can help to advance your therapeutic program.

The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.
 

Download Resource

The collaborative advantage in therapeutic genome editing

Download Infographic
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.